9/22/25 16:29 | 9/18/25 | ACHV | Achieve Life Sciences, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Stewart Richard Alistair | WA | DO | CEO | M.d | 0 | 0.00 | 0 | 298 | | 230 | D | | | | | | | | | | | | | | |
9/22/25 16:29 | 9/18/25 | ACHV | Achieve Life Sciences, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Stewart Richard Alistair | WA | DO | CEO | S.d | -378 | 2.92 | 0 | -130 | -36 | 230 | D | | | | | | | | | | | | | | |
3/19/25 16:32 | 3/17/25 | ACHV | Achieve Life Sciences, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Stewart Richard Alistair | WA | DO | Chieve E | P | 29 | 2.86 | 0 | 10 | 19 | 62 | D | | | | | | | | | | | | | | |
4/23/24 16:31 | 4/19/24 | ACHV | Achieve Life Sciences, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Stewart Richard Alistair | WA | DO | Exec CB | M.d | 0 | 0.00 | 0 | 23 | 79 | 51 | D | | | | | | | | | | | | | | |
3/6/24 16:49 | 3/4/24 | ACHV | Achieve Life Sciences, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Stewart Richard Alistair | WA | DO | Exec CB | P.d | 46 | 4.59 | 0 | 10 | 35 | 39 | D | | | | | | | | | | | | | | |
5/1/23 17:51 | 4/28/23 | ACHV | Achieve Life Sciences, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Stewart Richard Alistair | WA | DO | Exec CB | M.d | 0 | 0.00 | 0 | 5 | 20 | 30 | D | | | | | | | | | | | | | | |
4/24/23 16:15 | 4/21/23 | ACHV | Achieve Life Sciences, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Stewart Richard Alistair | WA | DO | Exec CB | M.d | 0 | 0.00 | 0 | 23 | 501 | 27 | D | | | | | | | | | | | | | | |
4/29/22 16:46 | 4/28/22 | ACHV | Achieve Life Sciences, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Stewart Richard Alistair | WA | DO | Exec CB | M.d | 0 | 0.00 | 0 | 5 | 52 | 15 | D | | | | | | | | | | | | | | |
5/28/19 06:01 | 5/23/19 | ACHV | Achieve Life Sciences, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Stewart Richard Alistair | WA | DO | CB,CEO | P | 63 | 3.61 | 0 | 18 | 8 | 237 | D | | | | | | | | | | | | | | |